JP2023552917A5 - - Google Patents
Info
- Publication number
- JP2023552917A5 JP2023552917A5 JP2023549967A JP2023549967A JP2023552917A5 JP 2023552917 A5 JP2023552917 A5 JP 2023552917A5 JP 2023549967 A JP2023549967 A JP 2023549967A JP 2023549967 A JP2023549967 A JP 2023549967A JP 2023552917 A5 JP2023552917 A5 JP 2023552917A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- car
- transmembrane domain
- domain
- polynucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105722P | 2020-10-26 | 2020-10-26 | |
| US63/105,722 | 2020-10-26 | ||
| PCT/US2021/056709 WO2022093863A1 (en) | 2020-10-26 | 2021-10-26 | Chimeric antigen receptor (car) nk cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552917A JP2023552917A (ja) | 2023-12-19 |
| JP2023552917A5 true JP2023552917A5 (https=) | 2025-04-14 |
Family
ID=81256896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549967A Pending JP2023552917A (ja) | 2020-10-26 | 2021-10-26 | キメラ抗原受容体（ｃａｒ）ｎｋ細胞及びそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220127644A1 (https=) |
| EP (1) | EP4232560A4 (https=) |
| JP (1) | JP2023552917A (https=) |
| KR (1) | KR20230089570A (https=) |
| CN (1) | CN117136232A (https=) |
| AR (1) | AR123924A1 (https=) |
| AU (1) | AU2021372458A1 (https=) |
| CA (1) | CA3196656A1 (https=) |
| IL (1) | IL302335A (https=) |
| MX (1) | MX2023004811A (https=) |
| TW (1) | TW202233829A (https=) |
| WO (1) | WO2022093863A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4630567A2 (en) * | 2022-12-09 | 2025-10-15 | Research Institute at Nationwide Children's Hospital | Chimeric antigen receptor (car) t cells and uses thereof |
| EP4633649A1 (en) * | 2022-12-15 | 2025-10-22 | The Board of Trustees of the Leland Stanford Junior University | Homology-independent targeted dna insertion in human t cells |
| EP4720130A1 (en) * | 2023-06-01 | 2026-04-08 | Research Institute at Nationwide Children's Hospital | Cd-33 protein-binding compositions and methods related thereto |
| WO2025151923A1 (en) * | 2024-01-17 | 2025-07-24 | Newsouth Innovations Pty Limited | Apparatus for production of engineered cells |
| CN120118953A (zh) * | 2025-05-13 | 2025-06-10 | 之江实验室 | 一种car供体质粒、t细胞及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3307876B1 (en) * | 2015-06-10 | 2023-09-13 | ImmunityBio, Inc. | Modified nk-92 cells for treating cancer |
| CA3025667A1 (en) * | 2016-06-08 | 2017-12-14 | Intrexon Corporation | Cd33 specific chimeric antigen receptors |
| CA3030683C (en) * | 2016-07-12 | 2023-11-21 | Kite Pharma, Inc. | Antigen binding molecules and methods of use thereof |
| EP4029943A1 (en) * | 2017-05-08 | 2022-07-20 | Precision Biosciences, Inc. | Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof |
| WO2019237035A1 (en) * | 2018-06-08 | 2019-12-12 | Intellia Therapeutics, Inc. | Compositions and methods for immunooncology |
| JP7520826B2 (ja) * | 2018-10-17 | 2024-07-23 | クリスパー・セラピューティクス・アクチェンゲゼルシャフト | 導入遺伝子を送達するための組成物および方法 |
| BR112021008041A2 (pt) * | 2018-11-07 | 2021-08-10 | Crispr Therapeutics Ag | terapia contra o câncer com células imunitárias anti-cd33 |
| SG11202110613SA (en) * | 2019-03-27 | 2021-10-28 | Res Inst Nationwide Childrens Hospital | Generation of chimeric antigen receptor (car)-primary nk cells for cancer immunotherapy using a combination of cas9/rnp and aav viruses |
-
2021
- 2021-10-26 MX MX2023004811A patent/MX2023004811A/es unknown
- 2021-10-26 IL IL302335A patent/IL302335A/en unknown
- 2021-10-26 EP EP21887373.5A patent/EP4232560A4/en active Pending
- 2021-10-26 AU AU2021372458A patent/AU2021372458A1/en active Pending
- 2021-10-26 AR ARP210102971A patent/AR123924A1/es unknown
- 2021-10-26 KR KR1020237016747A patent/KR20230089570A/ko active Pending
- 2021-10-26 CN CN202180075720.2A patent/CN117136232A/zh active Pending
- 2021-10-26 WO PCT/US2021/056709 patent/WO2022093863A1/en not_active Ceased
- 2021-10-26 US US17/511,187 patent/US20220127644A1/en active Pending
- 2021-10-26 TW TW110139744A patent/TW202233829A/zh unknown
- 2021-10-26 JP JP2023549967A patent/JP2023552917A/ja active Pending
- 2021-10-26 CA CA3196656A patent/CA3196656A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023552917A5 (https=) | ||
| CN106566838B (zh) | 一种基于CRISPR-Cas9技术的miR-126全长基因敲除试剂盒及其应用 | |
| AU2020230334A1 (en) | Compositions and methods for immunooncology | |
| EP3423580A1 (en) | Crispr-cpf1-related methods, compositions and components for cancer immunotherapy | |
| CN111909966B (zh) | 一种制备经修饰的免疫细胞的方法 | |
| WO2016183236A1 (en) | Crispr/cas-related methods and compositions for treating hiv infection and aids | |
| US20220145333A1 (en) | Improved process for integration of dna constructs using rna-guided endonucleases | |
| JP2020528738A (ja) | ｉｎ ｖｉｔｒｏでＴ細胞中のターゲット遺伝子をノックアウトするための方法及び前記方法で使用されるｃｒＲＮＡ | |
| US11998567B2 (en) | Engineered chimeric guide RNA and uses thereof | |
| WO2022012531A1 (zh) | 一种经修饰的免疫细胞的制备方法 | |
| CN110885799A (zh) | 一种基于腺病毒的基因编辑方法 | |
| JP2022527709A5 (https=) | ||
| JP2025122008A (ja) | 同種ｔ細胞およびその産生方法 | |
| US20200377878A1 (en) | Modified t cells and uses thereof | |
| US20250270546A1 (en) | Guide rnas and uses thereof | |
| WO2022015956A1 (en) | Improved process for dna integration using rna-guided endonucleases | |
| CN110564691A (zh) | Hla纯合子来源的通用型car-t细胞的制备方法 | |
| RU2021131306A (ru) | Получение первичных nk-клеток с химерными антигенными рецепторами (car) для иммунотерапии онкологических заболеваний с использованием комбинации cas9/рнп и вирусов aav | |
| WO2025117745A1 (en) | Methods and compositions for improving precision of endonuclease-mediated genome editing | |
| CN108977442B (zh) | 用于dna编辑的系统及其应用 | |
| WO2025040046A1 (zh) | 体内半衰期延长的工程化t细胞及其制备方法 | |
| HK40067933B (zh) | 同种异体t细胞和其产生方法 | |
| HK40067933A (en) | Allogeneic t-cells and methods for production thereof | |
| HK40097024A (zh) | 用於工程改造和选择具有期望表型的car t细胞的组合物和方法 | |
| JP2023531729A (ja) | キルスイッチを有するドナーｔ細胞 |